Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification

NCT02799173 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis
Lupus Erythematosus, Systemic

Interventions

BIOLOGICAL: RANKL/OPG ratio
DEVICE: bone densitometry
DEVICE: fan beam CT scan
DEVICE: Doppler ultrasound

Sponsor

Centre Hospitalier Universitaire, Amiens